Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques

Experimental Physiology

Volumn 93, Issue 5, 2008, Pages 564-569

  Zulli, Anthony ^a,b,c   Rai, Sudarshan ^a,b   Buxton, Brian F ^c   Burrell, Louise M ^a   Hare, David L ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Austin Health   (United States)

^c AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CD34 ANTIBODY; CELL PROTEIN; CHOLESTEROL; METHIONINE; PROTEIN OCTOMER 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; RABBIT; SPINDLE CELL;

EID: 42649129357     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.040204     Document Type: Article

References (31)

1. Blank RS, Swartz EA, Thompson MM, Olson EN & Owens GK (1995). A retinoic acid‐induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics. Circ Res 76, 742–749.
2. Bobe J, Montfort J, Nguyen T & Fostier A (2006). Identification of new participants in the rainbow trout (Oncorhynchus mykiss) oocyte maturation and ovulation processes using cDNA microarrays. Reprod Biol Endocrinol 4, 39.
3. Chappell MC, Pirro NT, Sykes A & Ferrario CM (1998). Metabolism of angiotensin‐(1–7) by angiotensin‐converting enzyme. Hypertension 31, 362–367.
4. Dechow C, Morath C, Peters J, Lehrke I, Waldherr R, Haxsen V, Ritz E & Wagner J (2001). Effects of all‐ trans retinoic acid on renin‐angiotensin system in rats with experimental nephritis. Am J Physiol Renal Physiol 281, F909–F919.
5. Diez‐Freire C, Vazquez J, Correa de Adjounian MF, Ferrari MF, Yuan L, Silver X, Torres R & Raizada MK (2006). ACE2 gene transfer attenuates hypertension‐linked pathophysiological changes in the SHR. Physiol Genomics 27, 12–19.
6. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE & Acton S (2000). A novel angiotensin‐converting enzyme‐related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res 87, E1–E9.
7. Faherty S, Kane MT & Quinlan LR (2005). Self‐renewal and differentiation of mouse embryonic stem cells as measured by Oct 4 gene expression: effects of lif, serum‐free medium, retinoic acid, and dbcAMP. In Vitro Cell Dev Biol Anim 41, 356–363.
8. Ferrario CM (2006). Angiotensin‐converting enzyme 2 and angiotensin‐(1–7): an evolving story in cardiovascular regulation. Hypertension 47, 515–521.
9. Ferreira AJ, Jacoby BA, Araujo CA, Macedo FA, Silva GA, Almeida AP, Caliari MV & Santos RA (2007). The nonpeptide angiotensin‐(1–7) receptor Mas agonist AVE‐0991 attenuates heart failure induced by myocardial infarction. Am J Physiol Heart Circ Physiol 292, H1113–H1119.
10. Guy JL, Jackson RM, Acharya KR, Sturrock ED, Hooper NM & Turner AJ (2003). Angiotensin‐converting enzyme‐2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 42, 13185–13192.
11. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G & Van Goor H (2007). The emerging role of ACE2 in physiology and disease. J Pathol 212, 1–11.
12. Harmer D, Gilbert M, Borman R & Clark KL (2002). Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 532, 107–110.
13. Iyer SN, Ferrario CM & Chappell MC (1998). Angiotensin‐(1–7) contributes to the antihypertensive effects of blockade of the renin‐angiotensin system. Hypertension 31, 356–361.
14. Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford‐Lenane C, Perlman S & McCray PB Jr (2005). ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 79, 14614–14621.
15. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F & Van Gilst WH (2002). Angiotensin‐(1–7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105, 1548–1550.
16. Ovitt CE & Scholer HR (1998). The molecular biology of Oct‐4 in the early mouse embryo. Mol Hum Reprod 4, 1021–1031.
17. Paul M, Poyan Mehr A & Kreutz R (2006). Physiology of local renin‐angiotensin systems. Physiol Rev 86, 747–803.
18. Pesce M & Scholer HR (2001). Oct‐4: gatekeeper in the beginnings of mammalian development. Stem Cells 19, 271–278.
19. Reudelhuber TL (2006). A place in our hearts for the lowly angiotensin 1–7 peptide? Hypertension 47, 811–815.
20. Santos RA, Ferreira AJ, Pinheiro SV, Sampaio WO, Touyz R & Campagnole‐Santos MJ (2005). Angiotensin‐(1–7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs 14, 1019–1031.
21. Scholer HR, Hatzopoulos AK, Balling R, Suzuki N & Gruss P (1989). A family of octamer‐specific proteins present during mouse embryogenesis: evidence for germline‐specific expression of an Oct factor. EMBO J 8, 2543–2550.
22. Sylvester I & Scholer HR (1994). Regulation of the Oct‐4 gene by nuclear receptors. Nucleic Acids Res 22, 901–911.
23. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G & Turner AJ (2000). A human homolog of angiotensin‐converting enzyme. Cloning and functional expression as a captopril‐insensitive carboxypeptidase. J Biol Chem 275, 33238–33243.
24. Zhong JC, Huang DY, Yang YM, Li YF, Liu GF, Song XH & Du K (2004). Upregulation of angiotensin‐converting enzyme 2 by all‐ trans retinoic acid in spontaneously hypertensive rats. Hypertension 44, 907–912.
25. Zulli A, Burrell LM, Buxton BF & Hare DL (2007a). ACE2 and AT4R are present in diseased human blood vessels. Eur J Histochem in press.
26. Zulli A, Burrell LM, Widdop RE, Black MJ, Buxton BF & Hare DL (2006). Immunolocalization of ACE2 and AT 2 receptors in rabbit atherosclerotic plaques. J Histochem Cytochem 54, 147–150.
27. Zulli A, Buxton BF, Black MJ & Hare DL (2005). CD34 Class III positive cells are present in atherosclerotic plaques of the rabbit model of atherosclerosis. Histochem Cell Biol 124, 517–522.
28. Zulli A, Buxton BF, Black MJ & Hare DL (2007b). Embryonic stem cells markers are present within rabbit atherosclerotic plaques. Histol Histopathol in press.
29. Zulli A, Hare DL, Buxton BF & Black MJ (2004). High dietary methionine plus cholesterol exacerbates atherosclerosis formation in the left main coronary artery of rabbits. Atherosclerosis 176, 83–89.
30. Zulli A, Merrilees M, Buxton BF & Hare DL (2007c). Human diseased arteries contain cells expressing leukocytic and embryonic stem cell markers. Human Pathol in press.
31. Zulli A, Widdop RE, Hare DL, Buxton BF & Black MJ (2003). High methionine and cholesterol diet abolishes endothelial relaxation. Arterioscler Thromb Vasc Biol 23, 1358–1363.